These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18347139)

  • 1. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
    Handeli S; Simon JA
    Mol Cancer Ther; 2008 Mar; 7(3):521-9. PubMed ID: 18347139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
    Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
    Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin.
    Liu J; Wang H; Zuo Y; Farmer SR
    Mol Cell Biol; 2006 Aug; 26(15):5827-37. PubMed ID: 16847334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
    Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
    J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Wnt/beta-catenin pathway by cPLA2alpha and PPARdelta.
    Han C; Lim K; Xu L; Li G; Wu T
    J Cell Biochem; 2008 Oct; 105(2):534-45. PubMed ID: 18636547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid activates β-catenin/T cell factor signaling, which contributes to the suppression of apoptosis in H19-7 cells.
    Sun Y; Kim NH; Ji L; Kim SH; Lee J; Rhee HJ
    Mol Med Rep; 2013 Dec; 8(6):1729-33. PubMed ID: 24145616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
    Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
    Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PPARγ2 by PPARγ1 through a functional PPRE in transdifferentiation of myoblasts to adipocytes induced by EPA.
    Luo H; Zhou Y; Hu X; Peng X; Wei H; Peng J; Jiang S
    Cell Cycle; 2015; 14(12):1830-41. PubMed ID: 25892270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells.
    Park S; Chun S
    Biochim Biophys Acta; 2011 Dec; 1810(12):1340-5. PubMed ID: 21763403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Peroxisome Proliferator-Activated Receptor (PPAR)-
    Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
    Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
    Mulholland DJ; Dedhar S; Coetzee GA; Nelson CC
    Endocr Rev; 2005 Dec; 26(7):898-915. PubMed ID: 16126938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.
    Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of beta-catenin signaling by PPAR gamma ligands.
    Lu D; Carson DA
    Eur J Pharmacol; 2010 Jun; 636(1-3):198-202. PubMed ID: 20303941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.
    Kril LM; Vilchez V; Jiang J; Turcios L; Chen C; Sviripa VM; Zhang W; Liu C; Spear B; Watt DS; Gedaly R
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3897-9. PubMed ID: 26243371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells.
    Jansson EA; Are A; Greicius G; Kuo IC; Kelly D; Arulampalam V; Pettersson S
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1460-5. PubMed ID: 15665104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARδ signaling regulates colorectal cancer.
    You M; Yuan S; Shi J; Hou Y
    Curr Pharm Des; 2015; 21(21):2956-9. PubMed ID: 26004416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.
    Guo F; Ren X; Dong Y; Hu X; Xu D; Zhou H; Meng F; Tian W; Zhao Y
    Gene; 2016 Jun; 584(1):31-37. PubMed ID: 26956036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription.
    Zeller J; Turbiak AJ; Powelson IA; Lee S; Sun D; Showalter HD; Fearon ER
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5814-20. PubMed ID: 24060489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin Pathway-Mediated PPARδ Expression during Embryonic Development Differentiation and Disease.
    Sidrat T; Rehman ZU; Joo MD; Lee KL; Kong IK
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.